Press Resease

Hemato Oncology Testing Market - Global Industry Analysis

Hemato Oncology Testing Market - By Cancer (Leukemia and Non-Hodgkin’s Lymphoma), By Cancer & Services (Assay Kits and Services), By End-User (Hospitals and Clinical Laboratories), By Technology (NGS, IHC, and PCR), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 11-Feb-2020 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4844 Status : Published

The global hemato oncology testing market in 2019 was valued at USD 2.0 billion and is anticipated to surpass USD 4.5 billion by 2025, at a CAGR of 15.1 % during the forecast period.

Description

The global Hemato oncology testing market was estimated at 2 (USD Billion) in 2019 and is projected to be valued at 4.5 (USD Billion) by 2025 at a CAGR of 15.1%. The report offers valuation and analysis of Hemato oncology testing market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).

Introduction

Hemato oncology testing encompasses the critical examination of blood disorders such as iron deficiency anemia, leukemia, lymphoma, sickle cell disorder, and hemophilia. Moreover, the terminology “hematology” is integrated with “oncology” in which both the oncologists as well as hematologists work collectively for treating blood cancer as well as lymphoma & leukemia.

Global Hemato Oncology Testing Market

Key Growth Drivers

The increase in the incidences of hematologic cancer, rise in the awareness about personalized medicine, and surge in the number of assays is anticipated to result in the massive growth of the Hemato oncology testing market over the forecast period.

Furthermore, geneticists provide Hemato oncologists with information pertaining to cancer genetics as well as diagnostic tests. This helps the latter in accurately diagnosing the patient's condition and selecting the apt anticancer therapy. All these aforementioned factors are anticipated to steer the market trends over the years ahead.

Based on cancer, the market is segregated into Leukemia and Non-Hodgkin’s Lymphoma. On the basis of Cancer  & services, the Hemato oncology testing industry is divided into assay kits and services. In terms of technology, the market is segmented into PCR, IHC, and NGS. Among these segments, NGS is likely to growth at the highest rate due to its beneficial features.

Region-wise, the Hemato oncology testing industry is sectored into Europe, Asia Pacific, North America, the Middle East and Africa, and Latin America. Furthermore, the Asia Pacific market is set to record the highest CAGR over the forecast timeline owing to the presence of a huge patient population base and focus of key participants on the expansion of their business portfolio in the Asia Pacific zone.

Key players involved in the Hemato oncology testing business and profiled in the report include Asuragen, Inc., Abbott Laboratories, MolecularMD, ARUP Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Adaptive Biotechnologies, Thermo Fisher Scientific, Inc., Illumina, Inc., Invivoscribe, Inc., Bio-Rad Laboratories, Inc., and ArcherDx, Inc.

The global Hemato oncology testing market is segmented as follows:

By Products & Service

  • Services
  • Assay Kits

By Technology

  • PCR
  • IHC
  • NGS
  • Cytogenetics
  • Others

By End User

  • Clinical laboratories
  • Hospitals
  • Academic & Research Institutes
  • Other End Users (CROs, Pharmaceutical & Biotechnology Companies)

By Cancer

  • Leukemia
    • Acute myeloid leukemia
    • Acute lymphocytic leukemia
    • Other leukemia (Chronic lymphocytic leukemia, chronic myeloid leukemia)
  • Lymphoma
    • Non-Hodgkin’s Lymphoma
    • Hodgkin’s Lymphoma
  • Other cancers (Myeloma, Myelofibrosis (MF), Essential Thrombocythemia)

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Table Of Content


List of Figures

1. Market research process
2. Market research methodology
3. Global Hemato Oncology Testing Market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Hemato Oncology Testing Market attractiveness, By Cancer 
6. Global Hemato Oncology Testing Market attractiveness, By Product & Services 
7. Global Hemato Oncology Testing Market attractiveness, By End-User 
8. Global Hemato Oncology Testing Market attractiveness, By Technology  
9. Global Hemato Oncology Testing Market share, By Cancer , 2018 and 2025
10. Global Hemato Oncology Testing Market by Leukemia, 2016–2025 (USD Billion)
11. Global Hemato Oncology Testing Market by Non-Hodgkin’s Lymphoma,2016–2025 (USD Billion)
12. Global Hemato Oncology Testing Market Share by Product & Services ,2018 and 2025 (USD Billion)
13. Global Hemato Oncology Testing Market by Services,2016–2025 (USD Billion)
14. Global Hemato Oncology Testing Market by Assay Kits,2016–2025 (USD Billion)
15. Global Hemato Oncology Testing Market Share by End-User   ,2018 and 2025 (USD Billion)
16. Global Hemato Oncology Testing Market by Hospitals,2016–2025 (USD Billion)
17. Global Hemato Oncology Testing Market, By Clinical Laboratories, 2016–2025 (USD Billion)
18. Global Hemato Oncology Testing Market Share by Technology   ,2018 and 2025 (USD Billion)
19. Global Hemato Oncology Testing Market by NGS,2016–2025 (USD Billion)
20. Global Hemato Oncology Testing Market, By PCR, 2016–2025 (USD Billion)
21. Global Hemato Oncology Testing Market, By IHC, 2016–2025 (USD Billion)
22. Global Hemato Oncology Testing Market share, by Region, 2018 and 2025
23. North America Hemato Oncology Testing Market, 2016–2025 (USD Billion)
24. Europe Hemato Oncology Testing Market, 2016–2025 (USD Billion)
25. Asia Pacific Hemato Oncology Testing Market, 2016–2025 (USD Billion)
26. Latin America Hemato Oncology Testing Market, 2016–2025 (USD Billion)
27. The Middle East and Africa Hemato Oncology Testing Market, 2016–2025 (USD Billion)
 


List of Tables

1. Global Hemato Oncology Testing Market: snapshot
2. Drivers of the Hemato Oncology Testing Market: impact analysis
3. North America Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
4. North America Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
5. North America Hemato Oncology Testing Market Revenue, By End-User , 2016–2025 (USD Billion)
6. North America Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
7. The U.S. Hemato Oncology Testing Market revenue, By Cancer , 2016–2025 (USD Billion)
8. The U.S. Hemato Oncology Testing Market revenue, By Product & Services, 2016–2025 (USD Billion)
9. The U.S. Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
10. The U.S. Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
11. Rest of North America Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
12. Rest of North America Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
13. Rest of North America Hemato Oncology Testing Market Revenue, By End-User, 2016–2025 (USD Billion)
14. Rest of North America Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
15. Europe Hemato Oncology Testing Market revenue, By Cancer , 2016–2025 (USD Billion)
16. Europe Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
17. Europe Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
18. Europe Hemato Oncology Testing Market Revenue, By Technology , 2016–2025 (USD Billion)
19. UK Hemato Oncology Testing Market revenue, By Cancer  ,2016–2025 (USD Billion)
20. UK Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
21. UK Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
22. UK Hemato Oncology Testing Market Revenue, By Technology , 2016–2025 (USD Billion)
23. France Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
24. France Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
25. France Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
26. France Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
27. Germany Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
28. Germany Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
29. Germany Hemato Oncology Testing Market Revenue, By End-User, 2016–2025 (USD Billion)
30. Germany Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
31. Rest of Europe Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
32. Rest of Europe Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
33. Rest of Europe Hemato Oncology Testing Market Revenue, By End-User, 2016–2025 (USD Billion)
34. Rest of Europe Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
35. Asia Pacific Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
36. Asia Pacific Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
37. Asia Pacific Hemato Oncology Testing Market Revenue, By End-User , 2016–2025 (USD Billion)
38. Asia Pacific Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
39. China Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
40. China Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
41. China Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
42. China Hemato Oncology Testing Market Revenue, By Technology  , 2016–2025 (USD Billion)
43. Japan Hemato Oncology Testing Market revenue, By Cancer , 2016–2025 (USD Billion)
44. Japan Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
45. Japan Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
46. Japan Hemato Oncology Testing Market Revenue, By Technology  , 2016–2025 (USD Billion)
47. India Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
48. India Hemato Oncology Testing Market revenue, By Product & Services, 2016–2025 (USD Billion)
49. India Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
50. India Hemato Oncology Testing Market Revenue, By Technology  , 2016–2025 (USD Billion)
51. Rest of Asia Pacific Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
52. Rest of Asia Pacific Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
53. Rest of Asia Pacific Hemato Oncology Testing Market Revenue, By End-User, 2016–2025 (USD Billion)
54. Rest of Asia Pacific Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
55. Latin America Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
56. Latin America Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
57. Latin America Hemato Oncology Testing Market Revenue, By End-User, 2016–2025 (USD Billion)
58. Latin America Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
59. Brazil Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
60. Brazil Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
61. Brazil Hemato Oncology Testing Market Revenue, By End-User  , 2016–2025 (USD Billion)
62. Brazil Hemato Oncology Testing Market Revenue, By Technology , 2016–2025 (USD Billion)
63. Rest of Latin America Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
64. Rest of Latin America Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
65. Rest of Latin America Hemato Oncology Testing Market Revenue, By End-User , 2016–2025 (USD Billion)
66. Rest of Latin America Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
67. The Middle East and Africa Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
68. The Middle East and Africa Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
69. The Middle East and Africa Hemato Oncology Testing Market Revenue, By End-User , 2016–2025 (USD Billion)
70. The Middle East and Africa Hemato Oncology Testing Market Revenue, By Technology , 2016–2025 (USD Billion)
71. Saudi Arabia Hemato Oncology Testing Market revenue, By Cancer, 2016–2025 (USD Billion)
72. Saudi Arabia Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
73. Saudi Arabia Hemato Oncology Testing Market revenue, By End-User , 2016–2025 (USD Billion)
74. Saudi Arabia Hemato Oncology Testing Market revenue, By Technology, 2016–2025 (USD Billion)
75. South Africa Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
76. South Africa Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
77. South Africa Hemato Oncology Testing Market Revenue, By End-User , 2016–2025 (USD Billion)
78. South Africa Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
79. Rest of the Middle East & Africa Hemato Oncology Testing Market revenue, By Cancer ,2016–2025 (USD Billion)
80. Rest of the Middle East & Africa Hemato Oncology Testing Market revenue, By Product & Services , 2016–2025 (USD Billion)
81. Rest of the Middle East & Africa Hemato Oncology Testing Market Revenue, By End-User, 2016–2025 (USD Billion)
82. Rest of the Middle East & Africa Hemato Oncology Testing Market Revenue, By Technology, 2016–2025 (USD Billion)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed